Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis

Beneficial effect ofLactococcus lactisNCC 2287 in a murine model of eosinophilic esophagitis

(2016) S. Holvoet et al.   ALLERGY

Milk Fermented with a 15-Lipoxygenase-1-Producing Lactococcus Lactis Alleviates Symptoms of colitis in a Murine Model

(2015) Tessalia Saraiva et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Pretreatment With L-Citrulline Positively Affects the Mucosal Architecture and Permeability of the Small Intestine in a Murine Mucositis Model

(2015) Maísa Mota Antunes et al.   JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia

(2015) Hisashi Adachi et al.   Lipids in Health and Disease

Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice

(2015) Silvia H. S. P. Pedroso et al.   MICROBIOLOGY-SGM

L-Arginine Pretreatment Reduces Intestinal Mucositis as Induced by 5-FU in Mice

(2015) Paola C. L. Leocádio et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Host lysozyme-mediated lysis ofLactococcus lactisfacilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons

(2015) Sonia A. Ballal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis

(2014) Meritxell Zurita-Turk et al.   BMC BIOTECHNOLOGY

Protective Effects of Lactococci Strains Delivering Either IL-10 Protein or cDNA in a TNBS-induced Chronic Colitis Model

(2014) Silvina del Carmen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Microbiota and their role in the pathogenesis of oral mucositis

(2014) B Vanhoecke et al.   ORAL DISEASES

Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis

(2014) Tessalia Luerce et al.   Gut Pathogens

Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy

(2013) Sewanti Atul Limaye et al.   CANCER

Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors

(2013) Daniel W Thorpe et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update

(2013) Jean Guy LeBlanc et al.   FEMS MICROBIOLOGY LETTERS

Antibacterial membrane attack by a pore-forming intestinal C-type lectin

(2013) Sohini Mukherjee et al.   NATURE

Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4

(2012) Pedro M.G. Soares et al.   CYTOKINE

Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats

(2012) Yifei Lv et al.   INFLAMMATORY BOWEL DISEASES

Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis

(2012) Clover Ching Man Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

5-Fluorouracil Induced Intestinal Mucositis via Nuclear Factor-κB Activation by Transcriptomic Analysis and In Vivo Bioluminescence Imaging

(2012) Chung-Ta Chang et al.   PLoS One

Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats

(2011) Luca D. Prisciandaro et al.   CANCER BIOLOGY & THERAPY

The Antibacterial Lectin RegIII  Promotes the Spatial Segregation of Microbiota and Host in the Intestine

(2011) S. Vaishnava et al.   SCIENCE

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis

(2010) Silvia Caluwaerts et al.   ORAL ONCOLOGY

Proteolytic activation of human pancreatitis-associated protein is required for peptidoglycan binding and bacterial aggregation

(2009) Péter Medveczky et al.   BIOCHEMICAL JOURNAL

Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice

(2009) Yosuke Nishitani et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile

(2009) Andrea M. Stringer et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy

(2009) Barbara A. Murphy et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

(2009) Stephen T. Sonis   ORAL ONCOLOGY

Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution

(2008) Pedro M. G. Soares et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Yoghurts Containing Probiotics Reduce Disruption of the Small Intestinal Barrier in Methotrexate-Treated Rats

(2008) E. Southcott et al.   DIGESTIVE DISEASES AND SCIENCES

Regulation of C-type Lectin Antimicrobial Activity by a Flexible N-terminal Prosegment

(2008) Sohini Mukherjee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lactobacillus fermentumBR11 and Fructo-Oligosaccharide Partially Reduce Jejunal Inflammation in a Model of Intestinal Mucositis in Rats

(2008) Cassie L. Smith et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Acidification is not involved in the early inhibition of Staphylococcus aureus growth by Lactococcus lactis in milk

(2007) Cathy Charlier et al.   INTERNATIONAL DAIRY JOURNAL